Find similar content

Source channel @githubtrending · Post #14979 · Jul 20

#typescript#agent_workflow#agentic_workflow#agents#ai#aiagents#anthropic#artificial_intelligence#automation#chatbot#deepseek#gemini#low_code#nextjs#no_code#openai#rag#react#typescript Sim Studio is an easy-to-use, open-source platform that lets you build AI workflows visually without coding by dragging and connecting blocks on a canvas. It supports many AI models and integrates with over 60 popular tools like Gmail, Slack, and Google Sheets. You can run workflows via chat, APIs, or scheduled jobs and deploy them as APIs or plugins. It also offers real-time collaboration and built-in monitoring. This helps you quickly create, test, and deploy AI-powered applications or automation, saving time and effort while allowing flexibility and control over your AI projects[1][2][3][4]. https://github.com/simstudioai/sim

Hashtags

#typescript #agent_workflow #agentic_workflow #agents #ai #aiagents #anthropic #artificial_intelligence #automation #chatbot #deepseek #gemini #low_code #nextjs #no_code #openai #rag #react

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment